Correlation Between Pfizer and Immune Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pfizer and Immune Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Immune Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Immune Pharmaceuticals, you can compare the effects of market volatilities on Pfizer and Immune Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Immune Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Immune Pharmaceuticals.
Diversification Opportunities for Pfizer and Immune Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Immune is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Immune Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immune Pharmaceuticals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Immune Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immune Pharmaceuticals has no effect on the direction of Pfizer i.e., Pfizer and Immune Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pfizer and Immune Pharmaceuticals
If you would invest (100.00) in Immune Pharmaceuticals on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Immune Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Pfizer Inc vs. Immune Pharmaceuticals
Performance |
Timeline |
Pfizer Inc |
Immune Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Immune Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Immune Pharmaceuticals
The main advantage of trading using opposite Pfizer and Immune Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Immune Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immune Pharmaceuticals will offset losses from the drop in Immune Pharmaceuticals' long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Immune Pharmaceuticals vs. MYT Netherlands Parent | Immune Pharmaceuticals vs. Maiden Holdings | Immune Pharmaceuticals vs. Brp Group | Immune Pharmaceuticals vs. United Fire Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |